Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of California, San Francisco
San Francisco, California
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 687. We're showing you the first 500 records. If you need every record from this institution, you can download all of our data at the ProPublica Data Store.
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
Shibani Pati | Conflict of Interest | Amgen | $450,000 - $499,999 | 2017 |
Carmen Peralta | Conflict of Interest | Cricket Health | $250,000 - $299,999 | 2018 |
Shibani Pati | Conflict of Interest | Amgen | $200,000 - $249,999 | 2017 |
David Kokel | Conflict of Interest | Teleos Therapeutics | $100,000 - $149,999 | 2015 |
Arturo Alvarez-Buylla | Conflict of Interest | Neurona Therapeutics | $80,000 - $99,999 | 2016 |
Arturo Alvarez-Buylla | Conflict of Interest | Neurona Therapeutics | $80,000 - $99,999 | 2015 |
John Rubenstein | Conflict of Interest | Neurona Therapeutics | $80,000 - $99,999 | 2015 |
Dean Sheppard | Conflict of Interest | Pliant Therapeutics | $60,000 - $79,999 | 2019 |
Feroz Papa | Conflict of Interest | OptiKira | $40,000 - $59,999 | 2015 |
John Rubenstein | Conflict of Interest | Neurona Therapeutics | $40,000 - $59,999 | 2015 |
Arturo Alvarez-Buylla | Conflict of Interest | Neurona Therapeutics | $40,000 - $59,999 | 2015 |
Kevan Shokat | Conflict of Interest | Revolution Medicines | $40,000 - $59,999 | 2019 |
Scott Oakes | Conflict of Interest | OptiKira, LLC | $40,000 - $59,999 | 2016 |
Arturo Alvarez-Buylla | Conflict of Interest | Neurona Therapeutics | $40,000 - $59,999 | 2016 |
Elizabeth Blackburn | Conflict of Interest | Telome health, Inc | $20,000 - $39,999 | 2013 |
Michael Lawton | Conflict of Interest | Carl Zeiss Meditec, Inc. | $20,000 - $39,999 | 2016 |
Jeffrey Lotz | Conflict of Interest | Applied Biomechanics | $20,000 - $39,999 | 2015 |
Elissa Epel | Conflict of Interest | Telome health, Inc | $20,000 - $39,999 | 2013 |
Yadong Huang | Conflict of Interest | E-Scape Bio | $20,000 - $39,999 | 2017 |
Kevan Shokat | Conflict of Interest | Revolution Medicines | $20,000 - $39,999 | 2019 |
Saul Villeda | Conflict of Interest | Alkahest | $20,000 - $39,999 | 2016 |
Joel White | Conflict of Interest | Skourtes Institute | $20,000 - $39,999 | 2016 |
Gregory Marcus | Conflict of Interest | InCarda Therapeutics | $20,000 - $39,999 | 2015 |
Mark Schiebler | Conflict of Interest | Healthmyne | $20,000 - $39,999 | 2019 |
Frederick Goldman | Conflict of Interest | Jazz Pharmaceuticals, Inc. | $10,000 - $19,999 | 2017 |
Carmen Peralta | Conflict of Interest | Cricket Health | $10,000 - $19,999 | 2018 |
Joel White | Conflict of Interest | Willamette Dental Group | $10,000 - $19,999 | 2016 |
Keith C. Meyer | Conflict of Interest | Medimmune, Inc. | $10,000 - $19,999 | 2015 |
Michael Lawton | Conflict of Interest | Stryker Corporation | $10,000 - $19,999 | 2015 |
Adam Gazzaley | Conflict of Interest | Akili Interactive Labs | $10,000 - $19,999 | 2013 |
Arturo Alvarez-Buylla | Conflict of Interest | Neurona Therapeutics | $5,000 - $9,999 | 2015 |
Scott K. Nagle | Conflict of Interest | Merck Pharmaceuticals | $5,000 - $9,999 | 2019 |
Corey Ford | Conflict of Interest | Teva Pharmaceuticals | $5,000 - $9,999 | 2017 |
Jue Lin | Conflict of Interest | Telomere Diagnostics | $5,000 - $9,999 | 2015 |
Michael Lawton | Conflict of Interest | Mizuho America, Inc. | $5,000 - $9,999 | 2016 |
Wei Yao | Conflict of Interest | Rabome | $5,000 - $9,999 | 2019 |
John Wiencke | Conflict of Interest | Cellintec LLC | $0 - $4,999 | 2018 |
Shuvo Roy | Conflict of Interest | Silicon Kidney | $0 - $4,999 | 2015 |
Scott Oakes | Conflict of Interest | OptiKira, LLC | $0 - $4,999 | 2016 |
Jeffrey Lotz | Conflict of Interest | NewVert | $0 - $4,999 | 2015 |
David Kokel | Conflict of Interest | Teleos Therapeutics | $0 - $4,999 | 2015 |
Jeffrey Lotz | Conflict of Interest | Nocimed, LLC | $0 - $4,999 | 2015 |
Jeffrey Lotz | Conflict of Interest | SMC Biotech | $0 - $4,999 | 2015 |
Louis Picker | Conflict of Interest | TomegaVax, Inc. | $0 - $4,999 | 2014 |
Jeffrey Lotz | Conflict of Interest | Relievant Medsystems | $0 - $4,999 | 2015 |
Shuvo Roy | Conflict of Interest | Silicon Kidney | $0 - $4,999 | 2013 |
Shuvo Roy | Conflict of Interest | Silicon Kidney | $0 - $4,999 | 2013 |
Mark Schiebler | Conflict of Interest | X-vax | $0 - $4,999 | 2019 |
Saul Villeda | Conflict of Interest | Alkahest | $0 - $4,999 | 2016 |
Mark Schiebler | Conflict of Interest | Stemina Biomarkers | $0 - $4,999 | 2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.